IT1223565B - Derivati dell'acido tiazolidin 4 carbossilico ad attivita' farmaceutica - Google Patents

Derivati dell'acido tiazolidin 4 carbossilico ad attivita' farmaceutica

Info

Publication number
IT1223565B
IT1223565B IT23126/87A IT2312687A IT1223565B IT 1223565 B IT1223565 B IT 1223565B IT 23126/87 A IT23126/87 A IT 23126/87A IT 2312687 A IT2312687 A IT 2312687A IT 1223565 B IT1223565 B IT 1223565B
Authority
IT
Italy
Prior art keywords
thiazolidin
carboxylic acid
acid derivatives
compounds
formula
Prior art date
Application number
IT23126/87A
Other languages
English (en)
Other versions
IT8723126A0 (it
Inventor
Bella Davide Della
Angelo Carenzi
Dario Chiarino
Franco Pellacini
Original Assignee
Zambon Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zambon Spa filed Critical Zambon Spa
Priority to IT23126/87A priority Critical patent/IT1223565B/it
Publication of IT8723126A0 publication Critical patent/IT8723126A0/it
Priority to DE88202956T priority patent/DE3882682T2/de
Priority to AT88202956T priority patent/ATE92053T1/de
Priority to EP88202956A priority patent/EP0322068B1/en
Priority to ES88202956T priority patent/ES2059497T3/es
Priority to US07/287,042 priority patent/US4952596A/en
Priority to JP63323214A priority patent/JP2856747B2/ja
Application granted granted Critical
Publication of IT1223565B publication Critical patent/IT1223565B/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/10—Expectorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/04—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D277/06—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Pyrrole Compounds (AREA)
IT23126/87A 1987-12-21 1987-12-21 Derivati dell'acido tiazolidin 4 carbossilico ad attivita' farmaceutica IT1223565B (it)

Priority Applications (7)

Application Number Priority Date Filing Date Title
IT23126/87A IT1223565B (it) 1987-12-21 1987-12-21 Derivati dell'acido tiazolidin 4 carbossilico ad attivita' farmaceutica
DE88202956T DE3882682T2 (de) 1987-12-21 1988-12-19 Thiazolidin-4-carbonsäure-Derivate mit pharmazeutischer Wirkung.
AT88202956T ATE92053T1 (de) 1987-12-21 1988-12-19 Thiazolidin-4-carbonsaeure-derivate mit pharmazeutischer wirkung.
EP88202956A EP0322068B1 (en) 1987-12-21 1988-12-19 Derivatives of thiazolidine-4-carboxylic acid having pharmacological activity
ES88202956T ES2059497T3 (es) 1987-12-21 1988-12-19 Derivados del acido tiazolidin-4-carboxilico dotados de actividad farmacologica.
US07/287,042 US4952596A (en) 1987-12-21 1988-12-21 Derivatives of thiazolidine-4-carboxylic acid having pharmacological activity
JP63323214A JP2856747B2 (ja) 1987-12-21 1988-12-21 チアゾリジン‐４‐カルボン酸の誘導体、その製造方法及び該誘導体を有効成分とする医薬組成物

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT23126/87A IT1223565B (it) 1987-12-21 1987-12-21 Derivati dell'acido tiazolidin 4 carbossilico ad attivita' farmaceutica

Publications (2)

Publication Number Publication Date
IT8723126A0 IT8723126A0 (it) 1987-12-21
IT1223565B true IT1223565B (it) 1990-09-19

Family

ID=11204066

Family Applications (1)

Application Number Title Priority Date Filing Date
IT23126/87A IT1223565B (it) 1987-12-21 1987-12-21 Derivati dell'acido tiazolidin 4 carbossilico ad attivita' farmaceutica

Country Status (7)

Country Link
US (1) US4952596A (it)
EP (1) EP0322068B1 (it)
JP (1) JP2856747B2 (it)
AT (1) ATE92053T1 (it)
DE (1) DE3882682T2 (it)
ES (1) ES2059497T3 (it)
IT (1) IT1223565B (it)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3818850A1 (de) * 1988-06-03 1989-12-07 Hoechst Ag Oligopeptide mit zyklischen prolin-analogen aminosaeuren
IT1230706B (it) * 1989-02-10 1991-10-29 Poli Ind Chimica Spa Derivati dell'acido 3 piroglutamoil tiazolidin 4 carbossilico e loro proprieta' farmacologiche.
NL9001955A (nl) * 1990-09-05 1992-04-01 Cedona Pharm Bv Nieuwe thiazolidinederivaten.
ATE201204T1 (de) * 1996-03-25 2001-06-15 Alcon Lab Inc Derivate der thiazolidine-4-carbonsäure als cytoprotektive mittel
US5756851A (en) * 1996-10-21 1998-05-26 Albemarle Corporation Production of nabumetone or precursors thereof
US5811425A (en) * 1997-03-04 1998-09-22 Abbott Laboratories Heterocyclic compounds as COX-2 inhibitors
JP2002501518A (ja) * 1997-05-30 2002-01-15 セルテック セラピューティックス リミテッド 抗炎症性チロシン誘導体
US6329372B1 (en) 1998-01-27 2001-12-11 Celltech Therapeutics Limited Phenylalanine derivatives
US6555562B1 (en) 1998-02-26 2003-04-29 Celltech R&D Limited Phenylalanine derivatives
GB9805655D0 (en) 1998-03-16 1998-05-13 Celltech Therapeutics Ltd Chemical compounds
US6521626B1 (en) 1998-03-24 2003-02-18 Celltech R&D Limited Thiocarboxamide derivatives
GB9811159D0 (en) 1998-05-22 1998-07-22 Celltech Therapeutics Ltd Chemical compounds
GB9811969D0 (en) * 1998-06-03 1998-07-29 Celltech Therapeutics Ltd Chemical compounds
GB9814414D0 (en) 1998-07-03 1998-09-02 Celltech Therapeutics Ltd Chemical compounds
GB9821061D0 (en) 1998-09-28 1998-11-18 Celltech Therapeutics Ltd Chemical compounds
GB9821222D0 (en) 1998-09-30 1998-11-25 Celltech Therapeutics Ltd Chemical compounds
GB9825652D0 (en) 1998-11-23 1999-01-13 Celltech Therapeutics Ltd Chemical compounds
GB9826174D0 (en) 1998-11-30 1999-01-20 Celltech Therapeutics Ltd Chemical compounds
US6518283B1 (en) 1999-05-28 2003-02-11 Celltech R&D Limited Squaric acid derivatives
US6534513B1 (en) 1999-09-29 2003-03-18 Celltech R&D Limited Phenylalkanoic acid derivatives
US6455539B2 (en) 1999-12-23 2002-09-24 Celltech R&D Limited Squaric acid derivates
WO2001079173A2 (en) 2000-04-17 2001-10-25 Celltech R & D Limited Enamine derivatives as cell adhesion molecules
US6545013B2 (en) 2000-05-30 2003-04-08 Celltech R&D Limited 2,7-naphthyridine derivatives
US6403608B1 (en) 2000-05-30 2002-06-11 Celltech R&D, Ltd. 3-Substituted isoquinolin-1-yl derivatives
EP1301488A1 (en) 2000-07-07 2003-04-16 Celltech R&D Limited Squaric acid derivatives containing a bicyclic heteroaromatic ring as integrin antagonists
CA2417059A1 (en) 2000-08-02 2002-02-07 Celltech R&D Limited 3-substituted isoquinolin-1-yl derivatives
CN102146062B (zh) * 2011-01-19 2013-04-24 山东大学 噻唑烷类神经氨酸酶抑制剂及其应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU195492B (en) * 1984-07-27 1988-05-30 Boehringer Biochemia Srl Process for producing 2-substituted thiazolidine derivatives with antitussive and mucus regulating action and pharmaceuticals comprising these compounds as active ingredient
HU200177B (en) * 1985-06-18 1990-04-28 Biogal Gyogyszergyar Process for producing thiazolidinecarboxylic acids and pharmaceutical compositions comprising such compounds
IT1196485B (it) * 1986-07-14 1988-11-16 Zambon Spa Derivati dell'acido tiazolidin-4-carbossilico ad attivita' farmaceutica

Also Published As

Publication number Publication date
ES2059497T3 (es) 1994-11-16
US4952596A (en) 1990-08-28
JP2856747B2 (ja) 1999-02-10
EP0322068B1 (en) 1993-07-28
DE3882682D1 (de) 1993-09-02
DE3882682T2 (de) 1994-02-24
EP0322068A1 (en) 1989-06-28
JPH01203373A (ja) 1989-08-16
IT8723126A0 (it) 1987-12-21
ATE92053T1 (de) 1993-08-15

Similar Documents

Publication Publication Date Title
IT1223565B (it) Derivati dell'acido tiazolidin 4 carbossilico ad attivita' farmaceutica
FI872864A (fi) Menetelmä farmaseuttisesti aktiivisten bentsimidatsolijohdannaisten valmistamiseksi
FI101624B1 (fi) Menetelmä terapeuttisesti käyttökelpoisten N-(3-hydroksi-4-piperidinyyli)(dihydrobentsofuraani-, dihydro-2H-bentsopyraani- tai dihydrobentsodioksiini)karboksamidijohdannaisten valmistamiseksi ja välituote
DE3881073D1 (de) Naphthalenverbindungen und antiallergische und antiinflammatorische pharmazeutische mittel.
ATE211729T1 (de) Therapeutisch wirksame verbindungen
NO167737C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tetrahydroimidazo(1,4)benzodiazepin-2-oner.
IT1196485B (it) Derivati dell'acido tiazolidin-4-carbossilico ad attivita' farmaceutica
DE3464244D1 (de) 1-(4'alkylsulfonylphenyl)-2-amino-1,3-propanediol n-substituted derivatives
ATE88176T1 (de) 2-hydroxy-3-aryloxy-propylaminderivate mit kardiovaskulaerer wirkung.
ES531480A0 (es) Derivados del acido d-2-(6-metoxi-2-naftil)-propionico
AU572374B2 (en) Azolyl-aroxymethyl-dimethylpentinols, their use as fungicides
IT1224404B (it) Composti attivi sul sistema cardiovascolare
IT1204959B (it) Composti dotati di attivita' antiallergica
IT1241515B (it) Sali dell'acido nicotinico con composti aminobenzilici e loro impiego farmaceutico".

Legal Events

Date Code Title Description
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19931124